FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

15850311000001109: Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56124201000001111 Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56124301000001119 Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Has VMP Oxycodone 5mg / Naloxone 2.5mg modified-release tablets true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Has specific active ingredient Naloxone hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Targinact 5mg/2.5mg modified-release tablets (Pilsco Ltd) 28 tablet Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Targinact 5mg/2.5mg modified-release tablets (CST Pharma Ltd) 28 tablet Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Myloxifin 5mg/2.5mg modified-release tablets (Zentiva Pharma UK Ltd) 28 tablet 2 x 14 tablets Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Oxyargin 5mg/2.5mg modified-release tablets (Viatris UK Healthcare Ltd) 28 tablet 2 x 14 tablets Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Targinact 5mg/2.5mg modified-release tablets (DE Pharmaceuticals) 28 tablet Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Targinact 5mg/2.5mg modified-release tablets (Napp Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Targinact 5mg/2.5mg modified-release tablets (Waymade Healthcare Plc) 28 tablet Is a True Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start